Effectiveness and economy of low-dose ondansetron.
Walton
S C
SC
Koenig
T J
TJ
D000970:Antineoplastic Agents / Q000009:adverse effects; D003362:Cost-Benefit Analysis; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy; D017294:Ondansetron / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy
D000970:Antineoplastic Agents; D017294:Ondansetron